“WCLC has been proud to participate in the Gift Responsibly Campaign in the past, and we are once again committed to supporting this important initiative in 2024,” said Kevin van Egdom, Director ...

The primary objective of the open-label, international, multicenter trial – led by EORTC – will be to assess whether tebentafusp can prevent or delay relapse in patients with primary ocular ...

Patients completed 2 questionnaires on quality of life, the 30-question EORTC Core Quality of Life questionnaire (EORTC QLQ-C30) and the EuroQoL EQ-5D descriptive system and the EQ visual analogue ...

At the World Conference on Lung Cancer (WCLC), Gilead unveiled data from its phase 2 EVOKE-02 study of already-approved TROP2 drug Trodelvy (sacituzumab govitecan), showing what it said was ...

Zenocutuzumab is the first FDA-approved treatment for NRG1-positive NSCLC and pancreatic adenocarcinoma. The eNRGy study demonstrated a 33% overall response rate in NSCLC and 40% in pancreatic ...

The drugmaker teased the results earlier this year but provided details of the hard data at WCLC, including that the combination reduced the risk of disease progression or death by 38% compared to ...